Introduction:
Under normal physiologic conditions, the level of adenosine in the tissue microenvironment is relatively low. 1 At the height of inflammation, the destruction of host tissue by a vigorous immune response combined with damaged microcirculation and hypoxia lead to increases in extracellular adenosine. The presence of adenosine in the microenvironment prevents further tissue destruction by inhibiting inflammation. 2, 3 The importance of the adenosine A 2A receptor (A 2A R) in mediating this negative feedback loop has been dramatically demonstrated in A 2A R null mice. 4 These knockout mice are unable to control inflammation, which leads to extensive, often fatal, tissue destruction.
For example, when immune-mediated liver inflammation was induced in mice by injecting Con A, the A 2A R null mice died due to massive immune-mediated liver destruction.
The inability of the thymus to eliminate all self-reactive T cells necessitates peripheral mechanisms of T cell tolerance to prevent tissue damage from autoreactive T cells. The role of clonal deletion and T cell anergy in maintaining peripheral tolerance has been demonstrated in a number of in vivo models. 5, 6 More recently, the roles of Foxp3 + and LAG-3 + regulatory T cells in peripheral tolerance has been better defined. 7, 8 Likewise, cell surface receptors such as CTLA-4 and PD-1 and cytokines such as IL-10
and TGF-β are believed to not only inhibit T cell activation but also promote peripheral T cell tolerance. [9] [10] [11] [12] In this report we identify extracellular adenosine as a novel inducer of peripheral T cell tolerance. We propose that tissue-derived adenosine acts through the A 2A R to generate peripheral T cell tolerance by inducing T cell anergy and adaptive regulatory T cells.
For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From Cell Culture: A.E7 is a clonotypic CD4 + , Th1 T cell clone specific for pigeon cytochrome c (PCC) and is maintained as previously described. 13 A.E7s were rendered anergic with plate-bound anti-CD3 (1 µg/mL) or by incubation with APC, PCC (10 µM),
and CGS (1 µM).
Splenocytes and lymphocytes from A 2A R wt or null 6.5 + mice (see below) were harvested and enriched for CD4 + T cells via negative selection with the CD4 + T cell isolation kit and LS MACs column (all from Miltenyi Biotech, Auburn, CA). The T cells were then cultured in the presence or absence of 10 µg/mL HA and 1 µM CGS. The T cells were rechallenged for 3-4 hours with 100 µg/mL HA, GolgiStop (BD PharMingen), and irradiated APCs.
cAMP Production: Total cAMP of naïve or previously activated cells were assayed with the Biotrak EIA system (Amersham Biosciences, Buckinghamshire, UK).
Microarray:
In vitro microarray was performed as previously described. 14 In vivo microarray was performed as previously described.
8
Transgenic Mice: The C3HA expressing transgenic (recipient) mice express hemagglutinin (HA) under the rat C3 promoter and has been previously described. 15 The HA-specific TCR-transgenic mouse line 6.5 (donor mice) has been previously described. 8 A 2A R -/-mice were bred to this 6.5 mouse line. LAG-3 knockout mice on a C57/B6 were a generous gift of Dr. Dario Vignali. The LAG-3 KO genotype was bred onto a B10.D2
6.5 + TCR background. All experiments involving the mice were performed in accordance with protocols approved by the Animal Care and Use Committee of The Johns Hopkins University School of Medicine.
5C.C7 TCR-transgenic Rag2
-/-mice on a B10.A background were purchased from Taconic. T cells from 5C.C7 mice are specific for pigeon cytochrome c.
Adoptive Transfer: Clonotypic CD4 + T cells were harvested from 6.5 + transgenic mice.
The unfractionated population was resuspended to contain 1.2x10 6 EMSA: Nuclear extracts from CD4 + purified 6.5 + T cells that were prepared. The AP-1 probe was: 5'-CGC TTG ATG ACT CAG CCG GAA-3'. The NFκB probe was: 5'-AGT TGA GGG GAC TTT CCC AGG C-3'.
RT-PCR:
For in vitro studies, 5C.C7 splenocytes were stimulated overnight with 10 µM PCC in the presence or absence of 1 µM CGS. mRNA was isolated with Trizol and cDNA was generated. RT-PCR was performed as previously described. 14 For in vivo studies, recipient C3HA mice were given 1.2x10 6 6.5 + donor T cells as described above. On Day 3, donor T cells were sorted and cDNA generated as above.
RT-PCR was performed as previously described.
14 LAG-3 primers and probe sets used were: Primer 5′-ACATCAACCAGACAGTGGCCA-3′/Primer 5′-GCATCCCCTGGTGAAGGTC-3′/Probe 5′-6FAM-
CCCACTCCCATCCCGGCCC-TAMRA-3′
FoxP3 primers and probe sets used were: Primer 5′-GGC CCT TCT CCA GGA CAG A-3′/Primer 5′-GCT GAT CAT GGC TGG GTT GT -3′/Probe 5′-6FAM-ACT TCA TGC   ATC AGC TCT CCA CTG TGG ATT AT-TAMRA-3′ For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From IL-6 and TGF-β primers and probe sets were purchased from Applied Biosystems (Foster City, CA).
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Driving Conditions: 4x10 6 5C.C7 splenocytes were stimulated as previously described. 16 Briefly, cells were stimulated in media containing TGF-β (5 ng/mL), IL-6 (20 ng/mL) and anti-IL-4 and anti-IFN-γ blocking antibodies (10 µg/mL).
Statistics:
Quantitative data were expressed as mean ± standard deviation and compared using paired Student t tests. Values of p < 0.05 were considered significant and are indicated by an asterisk (*).
Results:
A 2A R expression is induced by Signal 1 alone in an NF-AT dependent fashion
Rao and colleagues have proposed that the genes that promote T cell anergy are induced by NF-AT in the absence of AP-1. If Cyclosporine A (CSA), which inhibits the translocation of NF-AT to the nucleus, is added during priming, the induction of anergy is inhibited ( Figure S1A ). We established a microarray database of T cells stimulated under conditions that promote or inhibit the induction of anergy and devised a novel statistical algorithm (hypothesis-based analysis of microarray or HAM) to analyze this data. 14, 17 The adenosine A 2A receptor was among the NF-AT-dependent genes that showed increased expression upon TCR engagement and was inhibited by CSA ( Figure   S1B ). For comparison, the adenosine A 1 receptor expression was not regulated by TCR signaling. The adenosine A 2B receptor displayed a similar, although less robust, expression profile to the A 2A R. Previous studies have clearly demonstrated the ability of the A 2A R to inhibit T cell activation both in vitro and in vivo. [19] [20] [21] [22] [23] In agreement with these studies, we found that however, in the presence of A 2A R signaling AP-1 binding was inhibited ( Figure 3D ).
Extracellular adenosine promotes long-term tolerance, in vivo
Using T cell clones and TCR transgenic primary T cells, we have shown that and not an increase in the general inflammatory milieu (for example, the host APCs are Wt and thus are responsive to the tissue-released adenosine).
We then asked whether we could pharmacologically induce tolerance, in vivo, by administering CGS to hosts that receive A 2A R competent 6.5 + T cells. We transferred a lethal dose of T cells followed by a 4-day course of CGS (2.5 mg/kg, ip, twice daily).
CGS treatment resulted in long term survival (30+ days) of 76% of the host mice, whereas only 24% of the vehicle treated hosts survived past day 9 ( Figure 5A ). We wanted to rule out that the ability of CGS to induce tolerance was simply due to the 
Rag2
-/-mice. 16 As seen in Figure 6A , CGS inhibited the expression of IL-6. In the same 
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Next we wanted to determine if the increase in LAG-3 corresponded with increased regulatory activity, in vivo. First, we transferred LAG-3 -/-6.5 + T cells into C3HA hosts and treated them with PBS or CGS. Consistent with our data in Figure 5A , 75% of the vehicle-treated mice receiving Wt clonotypic T cells died, while 100% of the CGS-treated mice survived. On the other hand, eliminating LAG-3 completely abolished the ability of CGS to promote survival, as 100% of the mice that received LAG-3 -/-T cells died, regardless of whether they were treated with CGS or not ( Figure 7D ). These data suggest that the upregulation of LAG-3 by A 2A R signaling plays a critical role in the ability of A 2A R signaling to promote tolerance and prevent tissue destruction.
Finally, we examined whether A 2A R signaling would lead to an increase in regulatory T cells that could mediate dominant-negative suppression upon subsequent rechallenge with naïve clonotypic cells. To this end we designed an in vivo suppression assay. In the C3HA model, the mice that survive the initial transfer of autoreactive T cells develop LAG-3 + regulatory T cells that can suppress a second challenge of autoreactive 6.5 + T cells and prevent lethal tissue destruction. 8 We injected the surviving mice of Figure 5A with a dose of T cells that would cause 100% death in naïve mice. cells. 30 The fact that the tumor microenvironment contains relatively high levels of adenosine suggests that tumor-derived adenosine may promote the generation of these regulatory cells. 40 22 For T cells, the consequences of TCR engagement are determined by the integration of multiple "accessory" signals. 41 Just as IL-10 and TGF-β have been associated with inhibiting immune responses and promoting tolerance induction, we
propose that tissue-derived adenosine, acts as a "metabokine," 42 to perform a similar function. Inasmuch as uric acid, HMG1-β, and low molecular weight species of extracellular matrix (i.e. hyaluronic acid) might be considered examples of tissue-derived
"danger" signals, we propose that tissue-derived adenosine, acting through the A 2A R, is one of many critical accessory signals that promote the induction of peripheral tolerance. [43] [44] [45] As such, during "non-infectious" tissue injury, adenosine released into the microenvironment may contribute to the maintenance of peripheral tolerance to de novo released self antigens. 
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For KO 6.5 + T cells were transferred into C3HA mice, harvested 3 days after adoptive transfer and sorted to >98% purity. LAG-3 expression was determined by Real Time PCR. c. Clonotypic 6.5 + T cells were transferred into C3HA mice which were treated with vehicle or CGS for 3 days following the adoptive transfer. The donor T cells were harvested and sorted to >98% purity. LAG-3 expression was determined by Real Time PCR. For a, b, and c, data are representative of 3 independent experiments, 3 mice per group. d. Survival curve of C3HA mice given Wt or LAG-3 KO T cells and a 4 day treatment with CGS. The "Wt Veh" and "LAG-3 KO CGS" both had 4 mice per group. For The "Wt CGS" and "LAG-3 KO Veh" both had 5 mice per group. Data are representative of 2 independent experiments. e. In vivo suppression assay in which vehicle-or CGS-treated C3HA mice (the survivors of Figure 5A 
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